— Why it moved
Why RKDA Stock Doubled Then Faded Today — June 11, 2026
A 1.8M-share float with 23% short interest doubled by late morning, then a $4M placement priced at $1.03 told the market where this was really headed.
What moved RKDA stock
Arcadia Biosciences is a nano-cap biosciences company valued under $2 million. The catalyst was financing, oddly enough. Arcadia signed purchase agreements for a $4 million private placement at $1.03 a share, H.C. Wainwright placing, and fresh-cash headlines on a ticker this small tend to get front-run.
The mechanics
The float is 1.8 million shares and about 23% of it was sold short. That combination doesn't need a good reason to double, it needs any reason. 122 million shares traded against that float, roughly 69 turnovers.
RKDA by the numbers
The alert window
Stock Pulse flagged it at 11:10 AM at $1.81. The top printed one minute later, $1.92 at 11:11, up 6.1%. One minute. Worse, the session high of $1.94 had already come five minutes before the alert. A real-time reader had essentially nothing to work with, and anyone chasing after 11:11 bought a fade.
How RKDA's move ended
It bled all afternoon and closed at $1.07, 41% below the alert, though still up 18% on the day. The placement priced stock at $1.03, and the $1.07 close sits right on that number, which is not a coincidence. When a nano-float pops on a placement headline, the offering price tells you where the sellers are aiming, and the close tends to find it.